The free L9 group showed modest correction of 18.7%, consistent with expected LNA ASO exposure in muscle; however this did not reach statistical significance ( Supplementary Fig.
← all excerpts
Bottlebrush polymer conjugates for enhanced antisense oligonucleotide therapy in myotonic dystrophy type 1.
1
—
—